Table 1 Baseline characteristics of approved patients enrolled in Italy in the avelumab MCC EAP
Characteristic | n = 102 |
|---|---|
Age | |
Median (range), years | 70.6 (41.0–92.0) |
< 65, n (%) | 27 (26.5) |
≥ 65, n (%) | 75 (73.5) |
Sex, n (%) | |
Female | 23 (22.5) |
Male | 78 (76.5) |
Data missing | 1 (1.0) |
ECOG PS, n (%) | |
0 | 52 (51.0) |
1 | 30 (29.4) |
2 | 4 (3.9) |
3 | 1 (1.0) |
Data missing | 15 (14.7) |
Line of therapy, n (%) | |
1 | 1 (1.0) |
≥ 2 | 101 (99.0) |